132
Participants
Start Date
March 24, 2022
Primary Completion Date
May 31, 2023
Study Completion Date
May 31, 2023
ME3183
ME3183 capsule
Placebo
Placebo capsule
Skin Search of Rochester, Inc., Rochester
International Dermatology Research, INC, Miami
Tennessee Clinical Research Center, Nashville
Owensboro Dermatology Associates, Owensboro
Qualmedica Research, LLC, Evansville
Shondra L. Smith, MD Dermatology & Advanced Aesthetics, Lake Charles
Northwest Arkansas Clinical Trials Center, Rogers
Dermatology Treatment and Research Center, Dallas
Center for Clinical Studies LTD, LLP, Houston
Studies in Dermatology, LLC, Cypress
Dermatology Clinical Research Center of San Antonio, San Antonio
Colorado Medical Research Center, Inc., Denver
University of Southern California, Los Angeles
Premier Clinical Research, Spokane
Laser Rejuvenation Clinics Edmonton D.T. Inc, Edmonton
SKiN Health, Cobourg
Sudbury Skin Clinique, Greater Sudbury
Dermatrials Research Inc., Hamilton
DermEffects, London
Lynderm Research Inc., Markham
DermEdge Research, Mississauga
Dermatology Ottawa Research Centre, Ottawa
The Centre for Dermatology, Richmond Hill
Toronto Research Centre, Toronto
K. Papp Clinical Research, Waterloo
Dr. David Gratton Dermatologue Inc., Montreal
Skinsense Medical Research, Saskatoon
Lead Sponsor
Meiji Pharma USA Inc.
INDUSTRY